Anitua, Eduardo https://orcid.org/0000-0002-8386-5303
Milani, Isidro
Martínez, Àlex
Cabello, Freddy
Prado, Roberto https://orcid.org/0000-0003-4767-7206
Padilla, Sabino https://orcid.org/0000-0001-9672-2881
Sanado, Luis
Article History
Received: 22 October 2024
Accepted: 11 December 2024
First Online: 16 January 2025
Declarations
:
: The authors declare that Eduardo Anitua is the Scientific Director of, and Sabino Padilla and Roberto Prado are scientists at the BTI—Biotechnology Institute I MAS D, a biomedical company that investigates the fields of re-generative medicine and PRGF-Endoret technology. Isidro Milani has nothing to disclose. Àlex Martínez has nothing to disclose. Freddy Cabello has nothing to disclose. Luis Sanado has nothing to disclose.
: The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of CEIm-E (protocol code BTIIMD-01-ER-24-DISC2). Informed consent was obtained from all subjects involved in the study.